Kway Jasmine
SEC CIK 1808135 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | CEO, Singapore Volition | 418.6K | $6,000 | — | 16 | 2022-04-07 | 2026-02-26 |
Most active insiders at VNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reynolds Cameron John | Pres, CEO, Dir | $63.1K | — |
| 2 | Innes Guy Archibald | Dir | $49.0K | — |
| 3 | STILL TIMOTHY I | Dir | $24.5K | — |
| 4 | Rubin Ethel | Dir | — | — |
| 5 | Retter Andrew | Chief Medical Off | — | — |
| 6 | Batchelor Ann-Louise | Group CMO | — | — |
| 7 | Henshall Mickie | Dir | — | — |
| 8 | Plummer Nicholas | GC - Volition Diagnostics | — | — |
| 9 | Nguyen Kim | Dir | — | — |
| 10 | Forterre Gael | Chief Commercial Off | — | — |
| 13 | Kway Jasmine | CEO - Singapore Volition | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +173.0K | 418.6K | +70% | $0 | |
| 2026-01-23 | 2026-01-22 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +42.0K | 245.6K | +21% | $0 | |
| 2025-08-19 | 2025-08-15 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +12.5K | 203.6K | +7% | $0 | |
| 2025-06-03 | 2025-06-01 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +8,327 | 191.1K | +5% | $0 | |
| 2025-03-04 | 2025-03-01 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +16.7K | 182.8K | +10% | $0 | |
| 2024-12-03 | 2024-12-01 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO, Singapore Volition | A - Grant | $0.00 | +15.2K | 166.1K | +10% | $0 | |
| 2024-09-04 | 2024-09-01 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +15.7K | 150.9K | +12% | $0 | |
| 2024-08-16 | 2024-08-15 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO, Singapore Volition | A - Grant | $0.00 | +16.8K | 135.2K | +14% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +13.6K | 118.5K | +13% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +28.5K | 104.9K | +37% | $0 | |
| I | 2023-08-25 | 2023-08-24 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | P - Purchase | $1.20 | +5,000 | 10.4K | +93% | +$6,000 |
| 2023-07-07 | 2023-07-05 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +22.1K | 76.4K | +41% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +18.4K | 54.4K | +51% | $0 | |
| 2022-10-14 | 2022-10-13 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +8,575 | 36.0K | +31% | $0 | |
| D | 2022-06-24 | 2022-06-23 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +17.8K | 27.4K | +186% | $0 |
| D | 2022-04-08 | 2022-04-07 | VNRX | VOLITIONRX LTD | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +9,604 | 9,604 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations